Owlet

Owlet has commercialized FDA-cleared wearable devices for infant vital sign monitoring at home. The Dream Sock provides real-time tracking of pulse rate, oxygen saturation, and sleep quality indicators for healthy babies. The BabySat system—available by prescription—offers hospital-grade pulse oximetry for infants with special medical needs. Both systems transmit data to a mobile app that alerts caregivers if readings fall outside preset ranges. Clinical studies support the effectiveness of in-home pulse oximetry in reducing adverse outcomes among high-risk infants.[5] The company has expanded into Europe with CE/UKCA-marked versions of its products.[6]